<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Fucosyltransferase-Strain-Engineering on Bioecon</title><link>https://en.bioecon.ru/technologies/fucosyltransferase-strain-engineering/</link><description>Recent content in Fucosyltransferase-Strain-Engineering on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 05 Jul 2026 22:49:34 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/fucosyltransferase-strain-engineering/index.xml" rel="self" type="application/rss+xml"/><item><title>Human milk oligosaccharides (HMOs)</title><link>https://en.bioecon.ru/technology/human-milk-oligosaccharides-hmos/</link><pubDate>Sun, 05 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/human-milk-oligosaccharides-hmos/</guid><description>Precision-fermented human milk oligosaccharides — 2&amp;rsquo;-fucosyllactose, LNnT and sialylated sugars produced by engineered E. coli or yeast — that feed infant-formula bifidobacteria and block pathogen attachment, now expanding from infant nutrition into adult gut-health supplements.</description></item></channel></rss>